我国正处在医改进行时,建立实施基本药物制度,提高基层医疗服务水平等都是改革重心。这些目标的实现,需要政府、企业与患者三方配合。默沙东公司在半年时间里做出的两个举动——原研药辛伐他汀降价支持基本药物制度建设和倾力支持“心航程”项目,早已超出一个企业的服务范围,更多的是出于企业所承担的社会责任。 At the time of medical reform in our country, establishing and implementing the basic drug system and improving the level of grass-roots medical service are the focuses of reform. The realization of these goals requires the cooperation of the government, enterprises and patients. Merck East in two months to make two moves - the original drug simvastatin prices to support the construction of basic drugs and Qingli support “heart flight ” project, already beyond the scope of services of an enterprise, more is out Corporate social responsibility.